Acquisition Completed

Leyden Labs acquisition of RIGImmune

Advisers

Leyden Labs

Acquirer

Not disclosed

Target
RIGImmune
Acquirer
Leyden Labs
Target based in
United States (unverified)
Buyer based in
Netherlands (unverified)
Completed
9 Sep 2026
Sector
Biotech
Tags
Biotech, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.